
Clinical characteristics and outcome of ICU admitted MERS corona virus infected patients
Author(s) -
Ashraf Abdel Halim,
Badr Alsayed,
Sameh Embarak,
Raja Taha Yaseen,
Salwa A Dabbous
Publication year - 2016
Publication title -
egyptian journal of chest diseases and tuberculosis/egyptian journal of chest diseases and tuberculosis
Language(s) - English
Resource type - Journals
eISSN - 2090-9950
pISSN - 0422-7638
DOI - 10.1016/j.ejcdt.2015.11.011
Subject(s) - medicine , sore throat , myalgia , sputum , abdominal pain , intensive care unit , bronchoalveolar lavage , mechanical ventilation , vomiting , nausea , pneumonia , surgery , lung , tuberculosis , pathology
Middle East Respiratory Syndrome (MERS) is a novel respiratory illness firstly reported in Saudi Arabia in 2012. It is caused by a new corona virus, called MERS corona virus (MERS-CoV). Most people who have MERS-CoV infection developed severe acute respiratory illness.